About

The IMPROVE-AD study is funded by the National Heart, Lung, and Blood Institute. The Duke Clinical Research Institute, together with other university partners, is conducting the study. The study plans to include up to 1,100 patients from 60 hospitals across the United States.

How long will IMPROVE-AD last?

The study will last about seven years. The study team expects being able to share study results in 2030.

Overall Study Timeline

Overall study timeline graphic

Study Leadership and Partners

The IMPROVE-AD study team is an experienced group of experts from several research centers.

Organizational Chart

Organizational chart for the IMPROVE-AD study

Where can I enroll in IMPROVE-AD?

Use the map below to find sites participating in IMPROVE-AD.

about